ASM Attendees - included with full registration
Non-ASM Attendees - AU$150
Please visit the registration page to register.
| Chairs: Gerry Fegan and Pam Taub |
|
|
| 1000-1020 | Metabolomic insights in relation to the heart and other organs: Linking diet and disease |
John O'Sullivan, NSW |
| 1020-1040 | Adiposity and cardiometabolic health - how much is too much? | Georgia Rigas, NSW |
| 1040-1100 | Is there an Indigenous cardio-metabolic gap? Culture, dietary habits, lifestyle factors | |
| 1100-1120 | Socioeconomics, ethnicity, policies and cardiometabolic diseases | Nishant Nundlall |
| 1120-1140 | Lifestyle or diet as a sole method of sustained weight loss - objective review of the evidence | Michael Miller, USA |
| 1140-1200 | Panel discussion | |
| 1200-1300 | Lunch | |
| Chairs: Girish Dwivedi and Judy de Haan | ||
| 1300-1320 | Connecting sleep with cardiometabolic health - applying advances to patient care | Linda Schachter, VIC |
| 1320-1340 | Triglyceride-rich lipoproteins in cardiometabolic diseases | Gerald Watts, WA |
| 1340-1400 | Population metabolic health | Kausik Ray, UK |
| 1400-1420 | EPA versus other treatments to prevent cardiovascular events | Preston Mason, USA |
| 1420-1440 | Redefining obesity management in cardiovascular prevention - can incretins replace lifestyle management? | Pam Taub, USA |
| 1440-1500 | Afternoon tea | |
| Chairs: Damon Bell and Elizabeth Robertson | ||
| 1500-1520 | Refining the management of resistant hypertension - emerging strategies and beyond | Markus Schlaich, WA |
| 1520-1540 | The intersection between cardiometabolic risk and metabolic associated fatty liver disease - new name, new insights | |
| 1540-1600 | Epigenetics, environmental factors and cardiovascular disease - where are we going? | Annemarie Hennessy, NSW |
| 1600-1620 | Bringing the kidneys into the party - guidance in patients with HF (addressing the AHA guidelines) | |
| 1620-1640 | Panel discussion | |
| 1640-1700 | Networking |
